| 000 | 01476 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515001126.0 | ||
| 264 | 0 | _c20050914 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1054-6863 | ||
| 024 | 7 |
_a10.1353/ken.2005.0014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIltis, Ana S | |
| 245 | 0 | 0 |
_aThird-party payers and the cost of biomedical research. _h[electronic resource] |
| 260 |
_bKennedy Institute of Ethics journal _cJun 2005 |
||
| 300 |
_a135-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBiomedical Research _xeconomics |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
| 650 | 0 | 4 | _aGovernment Regulation |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 |
_aHealth Services Accessibility _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance Coverage _xeconomics |
| 650 | 0 | 4 |
_aInsurance, Health, Reimbursement _xeconomics |
| 650 | 0 | 4 | _aMandatory Programs |
| 650 | 0 | 4 | _aMarketing |
| 650 | 0 | 4 |
_aMedicare _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aNeoplasms _xtherapy |
| 650 | 0 | 4 | _aPrivate Sector |
| 650 | 0 | 4 | _aPublic Policy |
| 650 | 0 | 4 | _aPublic Sector |
| 650 | 0 | 4 |
_aResearch Subjects _xeconomics |
| 650 | 0 | 4 | _aResearch Support as Topic |
| 650 | 0 | 4 |
_aTherapies, Investigational _xeconomics |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tKennedy Institute of Ethics journal _gvol. 15 _gno. 2 _gp. 135-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1353/ken.2005.0014 _zAvailable from publisher's website |
| 999 |
_c15783744 _d15783744 |
||